- Oberland pours up to $400M into MeiraGTx eye gene therapies<figure><div><img src="https://imgproxy.divecdn.com/nnTWCzHBd9_O2uNBVPF6xmxcO0M-nRFDpca5z-2Xchs/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDMwNzQzODA0LmpwZ…BioPharma Dive · 19d ago↗ source
- Kailera says obesity pill succeeds in late-stage trial in China<figure><div><img src="https://imgproxy.divecdn.com/sHvIDEWnHWODDKUtbWbg7nZxoWKQNqB4C54nc9z4iH4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc4ODI5MzYyLmpwZ…BioPharma Dive · 19d ago↗ source
- STAT+: The crumbling employer-based health insurance systemToday's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance.